about
A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physiciansTestosterone deficiency in the aging maleSafety issues of current analgesics: an updateImplications of analgesics use in osteoporotic-related pain treatment: focus on opioidsKappa Opioids, Salvinorin A and Major Depressive DisorderDecreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatoninThe Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A ReviewPain care for patients with epidermolysis bullosa: best care practice guidelines.Methadone induces testosterone suppression in patients with opioid addiction.Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions.Changes in serum biochemical factors associated with opium addiction after addiction desertion.Enhanced inhibitory synaptic transmission in the spinal dorsal horn mediates antinociceptive effects of TC-2559.The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism.Is opium addiction a risk factor for bone loss?Informed consent in opioid therapy: a potential obligation and opportunity.Opioids and endocrine dysfunctionFailed back surgery syndrome: a suggested algorithm of care.Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients.Diagnosis and management of testosterone deficiencyA Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's GuidePvuII and XbaI polymorphisms of estrogen receptor-α and the results of estroprogestagen therapy in girls with functional hypothalamic amenorrhea - preliminary studyA Psychiatric Presentation of Adrenal Insufficiency: A Case Report.A case of hypogonadotropic hypogonadism caused by opioid treatment for nonmalignant chronic painEffect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in ratsThe association of opioid use with incident lower extremity fractures in spinal cord injury.Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy.Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIVPolyanalgesic Consensus Conference--2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain.Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control.Achieving effective control in cancer pain: a review of current guidelines.A review on hematological factors in opioid-dependent people (opium and heroin) after the withdrawal period.Opioid-induced endocrinopathy in cancer patients: an underestimated clinical problem.Hormone testing and treatment enters pain care.History and present state of targeted intrathecal drug delivery.New horizons in testosterone and the ageing male.Opioid Related Endocrinopathy.Prevalence of androgen deficiency in chronic spinal cord injury patients suffering from erectile dysfunction.The impact of drugs on male fertility: a review.Pain and sex hormones: a review of current understanding.Opioid-Induced Androgen Deficiency (OPIAD): Diagnosis, Management, and Literature Review.
P2860
Q24602168-44AED286-FDBA-4DE3-8B20-97CA0592EA34Q26770414-ED11AB54-E77A-4743-B18C-3C192067FE8BQ26777293-CCAB6986-0053-47A2-BFB8-38AB190FE4BDQ28071550-9C8BD66E-F708-44A6-A493-E5CA095C311EQ28075656-5E98B2B7-EA6B-4ADA-9EE5-5690DF97C6AAQ28566666-2EE78DDE-0376-48CC-A9C3-F8F4A8DB7371Q30235088-01211541-CA45-4423-BB15-C8C6558DD155Q30590549-421FE0F4-0A56-4F15-937A-98528E19FFC5Q34085814-EDE0E964-0DCE-4FEF-92C4-3A0B5D6FAD9CQ34773536-D3B28AD4-51A9-494F-81FD-6BF6AF57F31AQ35160980-415EB952-FAFF-44CF-BEAE-FE0759FCE0B1Q35181505-876CF17B-2105-4A00-B31F-D1ECAAAD252CQ35284151-E6F4EEC1-1523-4434-87F3-28A4EFF1B2BDQ36022488-B05D7422-A84F-474D-9017-164DE6E4EF9BQ36083877-CB388FAD-C7E9-4E03-B99C-9CDB17A57925Q36110423-0696945C-B875-4E4E-BB9F-CE7B44526D95Q36110458-FAC339E5-35AA-4CEC-880C-73DE0707C216Q36194004-FF4B5798-F628-4D52-8ECF-A36EB800058BQ36293061-BC8DCB0C-860B-44EF-8C0C-AB11090F0E6CQ36302851-CD642B5B-7F57-4D73-8E49-E82AF46EF027Q36423009-E8E4D0F3-AB16-47EA-9097-FAF08F4AE4F2Q36518650-F5641A9A-8C7A-4997-B187-F8083193062EQ36522862-54FA8A64-69D0-4712-961D-DAD4B5552AA1Q36629106-FE42E71A-B9A7-4AEE-938D-D944CD7AEA31Q36679731-E11CFE1B-D79E-4326-8A83-D1A0ACA07ABBQ36893653-CE67F842-E191-49E5-B31A-EA5BCEC7A8A6Q37222229-9E7ED2D5-8FAF-4832-B8F4-3B627F1FBBB6Q38030985-7A3DE16C-6CC9-460D-8582-ADC2301B2E25Q38077182-E55FBAF3-CF50-4CEE-AF35-008E1D37E240Q38172806-02C9A465-372D-42EF-A332-BB2EF947FA6FQ38185030-97A89DF9-150A-4B8B-AC77-D7E04E3FB5C1Q38185319-AB2A3E55-3027-49E5-B146-BA49931884A0Q38285093-2DA2283A-010D-431C-BA13-3C811663FA69Q38339113-F7CD8EF8-2CF6-4227-897D-D7D8783F040DQ38349680-97FADD81-83CA-4483-AD64-C0B7240A0285Q38605861-A5D7F596-32BD-4044-AF23-C9AC8D913E40Q38717756-D4D2F366-E530-4D76-8F2B-7AE0DFEB681FQ38722243-87F58947-4F51-46E3-9E8C-3D7DD6DCECA5Q38777430-BA7805E3-EA37-46E1-AF7A-F462FD35E202Q38825193-4CD3D9DF-E9C6-41EC-88E7-4B492FB6E1DE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of opioids on the endocrine system.
@en
The impact of opioids on the endocrine system.
@nl
type
label
The impact of opioids on the endocrine system.
@en
The impact of opioids on the endocrine system.
@nl
prefLabel
The impact of opioids on the endocrine system.
@en
The impact of opioids on the endocrine system.
@nl
P1476
The impact of opioids on the endocrine system.
@en
P2093
Nathaniel Katz
Norman A Mazer
P304
P356
10.1097/AJP.0B013E3181850DF6
P407
P577
2009-02-01T00:00:00Z